Androgen Deficiency MOC Live Learning Session

Androgen Deficiency MOC Live Learning Session
With faculty authors, participants will review questions from the Androgen Deficiency MOC. This case-based tool contains 25 practice-related questions on androgen deficiency disorders. These questions have been approved by the ABIM for 10 MOC points toward self-assessment of medical knowledge. The registration fee includes post-session online access to the module, where participants can complete questions for MOC credit.
NOTE ABOUT MOC: If you have already purchased the Androgen Deficiency MOC module, contact Society Services about a discounted registration fee. MOC points can only be earned by completing the online module, not by attending the live learning session.
Target Audience
This continuing medical education activity should be of substantial interest to physicians seeking recertification in endocrinology and/or individuals seeking review and self-assessment in androgen deficiency syndromes in men.
Learning Objectives
- Diagnose androgen deficiency syndromes in men
- Select appropriate therapeutic options for patients with diagnosed androgen deficiency
- Effectively manage prescribed therapies for these patients
Additional Information
Shehzad Basaria, MD; Brigham and Women's Hospital/Harvard Medical School
Alvin Matsumoto, MD; University of Washington
Disclosure Policy
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to The Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported relevant financial relationships:
Alvin M Matsumoto, MD has received research support from AbbVie and GSK, a consulting fee from AbbVie, Endo Pharmaceuticals, Clarus Therapeutics and Lilly and royalties from UpToDate.
Shehzad Basaria, MD is a consultant for Eli Lilly.
The following faculty reported no relevant financial relationships: Bradley D. Anawalt, MD
The following content reviewer for the online module reported no relevant financial relationships: Alan C. Dalkin, MD
The medical editor for the online module, Abbie L. Young, MS, CGC, ELS(D), reported no relevant financial relationships.
Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.
Available Credit
- 3.25 AMA PRA Category 1 Credits™
- 3.25 CME Certificate of Participation